Clicky

BioCryst Pharmaceuticals, Inc.(BCRX) News

Date Title
Oct 11 Is BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) The Top Stock With Improving Technical Ratings According To Piper Sandler?
Oct 10 BioCryst to Present New Real-World Evidence on Long-Term Prophylaxis in HAE, including ORLADEYO® (berotralstat), at the American College of Allergy, Asthma & Immunology 2024 Annual Scientific Meeting
Oct 9 BioCryst Pharmaceuticals, Inc. (BCRX) Surpasses Revenue Expectations by $11 Million in Q2
Oct 7 BioCryst (BCRX) Upgraded to Buy: Here's Why
Oct 2 Enanta Pharmaceuticals (ENTA) Surges 5.6%: Is This an Indication of Further Gains?
Oct 2 BioCryst Begins Enrollment in Phase 1 Trial Evaluating BCX17725, a KLK5 Inhibitor, for the Treatment of Netherton Syndrome
Oct 1 BioCryst Secures Major US Health Department Influenza Drug Deal
Oct 1 BioCryst secures $69m contract from US to supply RAPIVAB for influenza
Sep 30 With 80% institutional ownership, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) is a favorite amongst the big guns
Sep 30 U.S. Government Awards BioCryst $69 Million RAPIVAB® (peramivir injection) Contract for Strategic National Stockpile
Sep 6 BioCryst Presents New ORLADEYO® (berotralstat) Data at 7th Bradykinin Symposium
Sep 5 BioCryst Appoints Dr. Donald Fong Chief Medical Officer
Aug 29 High Growth Tech Stocks To Watch In August 2024
Jul 30 Zoetis (ZTS) Earnings Expected to Grow: Should You Buy?
Jul 29 Will BioCryst Pharmaceuticals (BCRX) Report Negative Earnings Next Week? What You Should Know
Jun 26 BioCryst Pharmaceuticals Insiders Added US$1.05m Of Stock To Their Holdings
May 15 Insider Buying: Chief R&D Officer Helen Thackray Acquires 30,000 Shares of BioCryst ...
May 15 Director Steven Galson Acquires 21,940 Shares of BioCryst Pharmaceuticals Inc (BCRX)
May 15 Insider Buying: Charles Gayer Acquires 30,000 Shares of BioCryst Pharmaceuticals Inc (BCRX)
May 15 Insider Buying: CFO Anthony Doyle Acquires Shares of BioCryst Pharmaceuticals Inc (BCRX)